Review



afatinib  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress afatinib
    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), <t>Afatinib</t> (1 μM) <t>(E),</t> <t>Osimertinib</t> (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Afatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 64 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/afatinib/pmc13122707-42-0-7?v=MedChemExpress
    Average 94 stars, based on 64 article reviews
    afatinib - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "C-terminal interleukin 1 alpha (IL-1α) overexpression drives EMT and a vulnerability to ferroptosis in HNSCC"

    Article Title: C-terminal interleukin 1 alpha (IL-1α) overexpression drives EMT and a vulnerability to ferroptosis in HNSCC

    Journal: Redox Biology

    doi: 10.1016/j.redox.2026.104172

    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), Afatinib (1 μM) (E), Osimertinib (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Figure Legend Snippet: IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), Afatinib (1 μM) (E), Osimertinib (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.

    Techniques Used: Over Expression, Expressing, Western Blot, Control



    Similar Products

    94
    MedChemExpress afatinib
    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), <t>Afatinib</t> (1 μM) <t>(E),</t> <t>Osimertinib</t> (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Afatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/afatinib/pmc13122707-42-0-7?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    afatinib - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Thermo Fisher 96 well plates
    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), <t>Afatinib</t> (1 μM) <t>(E),</t> <t>Osimertinib</t> (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    96 Well Plates, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/afatinib/pm42143334-64-11-13?v=Thermo+Fisher
    Average 94 stars, based on 1 article reviews
    96 well plates - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    93
    TargetMol afatinib
    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), <t>Afatinib</t> (1 μM) <t>(E),</t> <t>Osimertinib</t> (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Afatinib, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/afatinib/pmc13010945-33-1-54?v=TargetMol
    Average 93 stars, based on 1 article reviews
    afatinib - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress afatinib dimaleate
    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), <t>Afatinib</t> (1 μM) <t>(E),</t> <t>Osimertinib</t> (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Afatinib Dimaleate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/afatinib/pm42025967-70-48-70?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    afatinib dimaleate - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress drugs
    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), <t>Afatinib</t> (1 μM) <t>(E),</t> <t>Osimertinib</t> (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Drugs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/afatinib/pmc13041752-414-19-21?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    drugs - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Ambeed Inc afatinib
    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), <t>Afatinib</t> (1 μM) <t>(E),</t> <t>Osimertinib</t> (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Afatinib, supplied by Ambeed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/afatinib/10__1016_slash_j__bioorg__2026__109912-42-35-39?v=Ambeed+Inc
    Average 86 stars, based on 1 article reviews
    afatinib - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    96
    Selleck Chemicals afatinib dimaleate
    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), <t>Afatinib</t> (1 μM) <t>(E),</t> <t>Osimertinib</t> (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Afatinib Dimaleate, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/afatinib/pm41828359-80-40-56?v=Selleck+Chemicals
    Average 96 stars, based on 1 article reviews
    afatinib dimaleate - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), Afatinib (1 μM) (E), Osimertinib (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.

    Journal: Redox Biology

    Article Title: C-terminal interleukin 1 alpha (IL-1α) overexpression drives EMT and a vulnerability to ferroptosis in HNSCC

    doi: 10.1016/j.redox.2026.104172

    Figure Lengend Snippet: IL-1α overexpression induces resistance to EGFR tyrosine kinase inhibitors. (A) Whole cell lysates were analyzed for EGFR and phosphorylated EGFR (pEGFR) expression by Western blot in control (CTL) and full-length (FL), N-terminal (NT) and C-terminal (CT) IL-1α overexpressed cells using α-Tubulin as a loading control, with quantification of protein expression shown in B and C. (D-G) Cell viability following 48 h treatment with Erlotinib (5 μM) (D), Afatinib (1 μM) (E), Osimertinib (1 μM) (F) and Silevertinib (1 μM) (G) was measured using MTT assays. Bars represent mean ± SEM from n = 3 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.

    Article Snippet: Afatinib, osimertinib and silivertinib (BDTX-1535) were from MedchemExpress (NJ, USA).

    Techniques: Over Expression, Expressing, Western Blot, Control